AAAAAA

   
Results: 1-10 |
Results: 10
STAGE IA-IIB HODGKINS-DISEASE - MANAGEMENT AND OUTCOME OF EXTENSIVE THORACIC INVOLVEMENT
Authors: HUGHESDAVIES L TARBELL NJ COLEMAN CN SILVER B SHULMAN LN LINGGOOD R CANELLOS GP MAUCH PM
Citation: L. Hughesdavies et al., STAGE IA-IIB HODGKINS-DISEASE - MANAGEMENT AND OUTCOME OF EXTENSIVE THORACIC INVOLVEMENT, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 361-369
TRANSCRIPTIONAL ACTIVATION FUNCTIONS IN BRCA2
Authors: MILNER J PONDER B HUGHESDAVIES L SELTMANN M KOUZARIDES T
Citation: J. Milner et al., TRANSCRIPTIONAL ACTIVATION FUNCTIONS IN BRCA2, Nature, 386(6627), 1997, pp. 772-773
SURAMIN INCREASES P53 PROTEIN-LEVELS BUT DOES NOT ACTIVATE THE P53-DEPENDENT G(1) CHECKPOINT
Authors: HOWARD SP PARK SJ HUGHESDAVIES L COLEMAN CN PRICE BD
Citation: Sp. Howard et al., SURAMIN INCREASES P53 PROTEIN-LEVELS BUT DOES NOT ACTIVATE THE P53-DEPENDENT G(1) CHECKPOINT, Clinical cancer research, 2(2), 1996, pp. 269-276
EXPRESSION OF THE HUMAN APURINIC ENDONUCLEASE GENE (APE) IN NORMAL AND MALIGNANT-TISSUES
Authors: HUGHESDAVIES L GALANOPOULOS T HARRISON L MAXWELL M ANTONIADES HN DEMPLE B
Citation: L. Hughesdavies et al., EXPRESSION OF THE HUMAN APURINIC ENDONUCLEASE GENE (APE) IN NORMAL AND MALIGNANT-TISSUES, International journal of oncology, 6(4), 1995, pp. 749-752
CDK2 KINASE PHOSPHORYLATES SERINE-315 OF HUMAN P53 IN-VITRO
Authors: PRICE BD HUGHESDAVIES L PARK SJ
Citation: Bd. Price et al., CDK2 KINASE PHOSPHORYLATES SERINE-315 OF HUMAN P53 IN-VITRO, Oncogene, 11(1), 1995, pp. 73-80
SERUM TROPONIN-T LEVELS DURING TREATMENT OF EARLY-STAGE BREAST-CANCER
Authors: HUGHESDAVIES L SACKS D RESCIGNO J HOWARD S HARRIS J
Citation: L. Hughesdavies et al., SERUM TROPONIN-T LEVELS DURING TREATMENT OF EARLY-STAGE BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2582-2584
FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER
Authors: HUGHESDAVIES L RESCIGNO J
Citation: L. Hughesdavies et J. Rescigno, FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8964), 1995, pp. 1582-1582
PARAMETRIAL INTERSTITIAL BRACHYTHERAPY FOR ADVANCED OR RECURRENT PELVIC MALIGNANCY - THE HARVARD STANFORD EXPERIENCE
Authors: HUGHESDAVIES L SILVER B KAPP DS
Citation: L. Hughesdavies et al., PARAMETRIAL INTERSTITIAL BRACHYTHERAPY FOR ADVANCED OR RECURRENT PELVIC MALIGNANCY - THE HARVARD STANFORD EXPERIENCE, Gynecologic oncology, 58(1), 1995, pp. 24-27
SEVERE ADVERSE CUTANEOUS REACTIONS TO DRUGS
Authors: HUGHESDAVIES L
Citation: L. Hughesdavies, SEVERE ADVERSE CUTANEOUS REACTIONS TO DRUGS, The New England journal of medicine, 332(14), 1995, pp. 959-959
TECHNICAL MODIFICATIONS REQUIRED TO TREAT CERVICAL CHEMODACTOMAS WITHSTEREOTAXIC RADIOSURGERY
Authors: HUGHESDAVIES L MANNARINO E ALEXANDER E KOOY H LOEFFLER JS
Citation: L. Hughesdavies et al., TECHNICAL MODIFICATIONS REQUIRED TO TREAT CERVICAL CHEMODACTOMAS WITHSTEREOTAXIC RADIOSURGERY, Surgical neurology, 41(5), 1994, pp. 418-420
Risultati: 1-10 |